UPDATE: UBS Upgrades Seattle Genetics
July 09, 2014 at 11:44 AM EDT
In a research note released Wednesday, UBS analyst Matthew Roden upgraded Seattle Genetics (NASDAQ: SGEN) from Neutral to Buy and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.